J&J To Launch CARTO XP In Japan
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson plans to launch CARTO XP, an electroanatomical mapping system to diagnose and treat irregular heart beat. Using imaging technology such as computer tomography, CARTO XP diagnoses IHB and treats it via catheter. The system also diagnoses and treats tachycardia cases, the most frequent cases among IHB patients. Priced at ¥60 million ($550,173), J&J expects CARTO XP to launch in January. The insurance reimbursement price for the catheter is yet to be decided. (Click here for more - may require subscription.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.